UnitedHealth Surges 9%, Humana Gains 5% as Earnings Strength Eases Medicare Advantage Concerns

UnitedHealth Group shares rose 9% from $323.48 to $351.40 after Q1 2026 results beat expectations and management raised full-year outlook. The move signals stronger-than-expected operating performance and improved forward visibility. The stock reaction indicates a meaningful but company-specific earnings catalyst rather than a broad market event.

Analysis

UnitedHealth Group shares rose 9% from $323.48 to $351.40 after Q1 2026 results beat expectations and management raised full-year outlook. The move signals stronger-than-expected operating performance and improved forward visibility. The stock reaction indicates a meaningful but company-specific earnings catalyst rather than a broad market event.